Simson Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 13 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.69 Cr
as on 03-12-2024
- Revenue 21.33%
(FY 2022)
- Profit 100.80%
(FY 2022)
- Ebitda 81.44%
(FY 2022)
- Net Worth 38.87%
(FY 2022)
- Total Assets 11.73%
(FY 2022)
About Simson Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.69 Cr.
Manga Penchala and Satyanarayana Penchala serve as directors at the Company.
- CIN/LLPIN
U74999TG2012PTC078553
- Company No.
078553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Simson Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manga Penchala  | Director | 13-Jan-2012 | Current |
| Satyanarayana Penchala | Director | 13-Jan-2012 | Current |
Financial Performance of Simson Life Sciences.
Simson Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.33% increase. The company also saw a substantial improvement in profitability, with a 100.8% increase in profit. The company's net worth Soared by an impressive increase of 38.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Simson Life Sciences?
In 2022, Simson Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Simson Pharma LimitedActive 6 years 8 monthsManga Penchala and Satyanarayana Penchala are mutual person
Amertha Life Sciences LlpActive 9 years 9 monthsManga Penchala and Satyanarayana Penchala are mutual person
- Wish Laboratories LlpActive 9 years 5 months
Manga Penchala and Satyanarayana Penchala are mutual person
- Simsol Medipharma LlpActive 4 years 2 months
Manga Penchala and Satyanarayana Penchala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jul 2020 | ₹2.06 Cr | Open |
Others Creation Date: 22 Jan 2018 | ₹1.07 Cr | Open |
Others Creation Date: 31 Jul 2017 | ₹5.54 M | Open |
How Many Employees Work at Simson Life Sciences?
Unlock and access historical data on people associated with Simson Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Simson Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simson Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
